Deals
Lilly Lifts 2026 Revenue Outlook To $91 Billion-$92 Billion, But $4.57 A Share In Deal Charges Cuts Profit Forecast
Third-quarter revenue rose 39% on Mounjaro and Zepbound, yet acquired research charges pulled the full-year earnings range lower.